Lamotrigine (LMT)
Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used off-label as an adjunct in treating clinical depression. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It is approved for the maintenance treatment of bipolar type I. Chemically unrelated to other anticonvulsants (due to lamotrigine's being a phenyltriazine), lamotrigine has many possible side-effects. Lamotrigine is generally accepted to be a member of the sodium channel blocking class of antiepileptic drugs, but it could have additional actions since it has a broader spectrum of action than other sodium channel antiepileptic drugs such as phenytoin and carbamazepine and is effective in the treatment of the depressed phase of bipolar disorder, whereas other sodium channel blocking antiepileptic drugs are not.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Lamotrigine (LMT) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Lamotrigine (LMT) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Lamotrigine (LMT) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Lamotrigine (LMT) CLIA Kit Customized Service Offer
n/a ELISA Kit for Lamotrigine (LMT) ELISA Kit Customized Service Offer